R. Martin Chavez Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity

R. Martin Chavez is Director of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 60,078 shares of RXRX, which is worth approximately $443,976. The most recent transaction as insider was on Apr 01, 2024, when has been sold 2,001 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 60.1K

0% 3M change

6.94% 12M change

Total Value Held $443,976

R. MARTIN CHAVEZ Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 01 2024	BUY Grant, award, or other acquisition	-	2,001 Added 3.22%	60,078 Class A Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	1,900 Added 3.17%	58,077 Class A Common Stock
Oct 02 2023	BUY Grant, award, or other acquisition	-	2,619 Added 4.45%	56,177 Class A Common Stock
Jul 03 2023	BUY Grant, award, or other acquisition	-	2,541 Added 4.53%	53,558 Class A Common Stock
Jun 16 2023	BUY Grant, award, or other acquisition	-	12,612 Added 19.82%	51,017 Class A Common Stock
Apr 03 2023	BUY Grant, award, or other acquisition	-	2,721 Added 6.62%	38,405 Class A Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	2,483 Added 6.51%	35,684 Class A Common Stock
Oct 03 2022	BUY Grant, award, or other acquisition	-	1,725 Added 4.94%	33,201 Class A Common Stock
Jul 01 2022	BUY Grant, award, or other acquisition	-	2,224 Added 6.6%	31,476 Class A Common Stock
Jun 14 2022	BUY Grant, award, or other acquisition	-	18,145 Added 38.28%	29,252 Class A Common Stock
Apr 01 2022	BUY Grant, award, or other acquisition	-	2,438 Added 18.0%	11,107 Class A Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	1,040 Added 10.71%	8,669 Class A Common Stock
Oct 01 2021	BUY Grant, award, or other acquisition	-	858 Added 10.11%	7,629 Class A Common Stock
Jul 01 2021	BUY Grant, award, or other acquisition	-	521 Added 7.14%	6,771 Class A Common Stock
Apr 20 2021	SELL Conversion of derivative security	-	6,250 Reduced 100.0%	0 Common Stock
Apr 20 2021	BUY Conversion of derivative security	-	6,250 Added 50.0%	6,250 Class A Common Stock
Apr 16 2021	BUY Grant, award, or other acquisition	-	6,250 Added 50.0%	6,250 Common Stock

Also insider at

GOOG

Alphabet Inc. Communication Services

RMC

R. Martin Chavez

Director

Salt Lake City, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Value

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Track Activities on RXRX

Account